Save your place

Sign in to WhoBought

Please try again later.

MetLife, Inc. (MET) institutional ownership

Latest close $93.37 Jul 21, 2026
Market cap$55.3B 52-week range SectorFinancial Services
Funds holding · Q1 2026
1,280
reported MET position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $592M
588 buyers · 692 sellers

MetLife, Inc. (MET) price and institutional activity

Dates

Q1 2026

$1.7B bought by 588 investors
T. Rowe Price Associates$191MArrowstreet Capital, Limited Partnership$133M +586 more
$2.3B sold by 692 investors
Norges-$607MAbn Amro Bank N.V.-$157M +690 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

MetLife, Inc. (MET) institutional activity · 692

Investor Type Est. change Change Δ Own Date
Norges · Exited −$607M
Change −8.1M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$607M −8.1M −100.0% Q1 2026
Abn Amro Bank N.V. · Reduced −$157M
Change −2.1M Date Q1 2026
Abn Amro Bank N.V. Reduced· Q1 2026 −$157M −2.1M Q1 2026
Diamond Hill Capital Management Inc · Reduced −$96M
Change −1.3M Date Q1 2026
Diamond Hill Capital Management Inc Reduced· Q1 2026 −$96M −1.3M Q1 2026
Bank of New York Mellon Corp · Reduced −$93M
Change −1.2M Date Q1 2026
Bank of New York Mellon Corp Reduced· Q1 2026 −$93M −1.2M Q1 2026
Dodge & Cox · Reduced −$85M
Change −1.1M Δ Own −2.2% Date Q1 2026
Dodge & Cox Reduced· Q1 2026 −$85M −1.1M −2.2% Q1 2026
Point72 Asset Management, L.P. · Exited −$73M
Change −969K Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −$73M −969K −100.0% Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −$69M −920K −44.8% Q1 2026
Clearbridge Investments, LLC · Reduced −$50M
Change −664K Date Q1 2026
Clearbridge Investments, LLC Reduced· Q1 2026 −$50M −664K Q1 2026
Squarepoint Ops LLC · Reduced −$45M
Change −604K Date Q1 2026
Squarepoint Ops LLC Reduced· Q1 2026 −$45M −604K Q1 2026
Adage Capital Partners Gp, L.L.C. · Exited −$45M
Change −600K Δ Own −100.0% Date Q1 2026
Adage Capital Partners Gp, L.L.C. Exited· Q1 2026 −$45M −600K −100.0% Q1 2026
Pzena Investment Management LLC · Reduced −$43M
Change −580K Date Q1 2026
Pzena Investment Management LLC Reduced· Q1 2026 −$43M −580K Q1 2026
Royal Bank of Canada · Reduced −$39M
Change −518K Date Q1 2026
Royal Bank of Canada Reduced· Q1 2026 −$39M −518K Q1 2026
Jennison Associates LLC · Reduced −$38M
Change −506K Date Q1 2026
Jennison Associates LLC Reduced· Q1 2026 −$38M −506K Q1 2026
Amundi · Reduced −$38M
Change −504K Date Q1 2026
Amundi Reduced· Q1 2026 −$38M −504K Q1 2026
Alliancebernstein L.P. · Reduced −$37M
Change −498K Date Q1 2026
Alliancebernstein L.P. Reduced· Q1 2026 −$37M −498K Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 692

Famous investor activity in MetLife, Inc. (MET)

MetLife, Inc. (MET) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Mumenthaler Christian Stephane · Director Grant (A) $51K
Price $87.40 Qty 587 Owned 3K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Mumenthaler Christian Stephane Director Grant (A) $87.40 587 $51K 3K Jun 16, 2026 Jun 18, 2026
Kennard William E. · Director Grant (A) $51K
Price $87.40 Qty 587 Owned 47K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Kennard William E. Director Grant (A) $87.40 587 $51K 47K Jun 16, 2026 Jun 18, 2026
Johnson Jeh C. · Director Grant (A) $51K
Price $87.40 Qty 587 Owned 9K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Johnson Jeh C. Director Grant (A) $87.40 587 $51K 9K Jun 16, 2026 Jun 18, 2026
McKenzie Diana · Director Grant (A) $51K
Price $87.40 Qty 587 Owned 25K Trade date Jun 16, 2026 Filed date Jun 18, 2026
McKenzie Diana Director Grant (A) $87.40 587 $51K 25K Jun 16, 2026 Jun 18, 2026
Hay Laura J. · Director Grant (A) $51K
Price $87.40 Qty 587 Owned 6K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Hay Laura J. Director Grant (A) $87.40 587 $51K 6K Jun 16, 2026 Jun 18, 2026
Hubbard Robert Glenn · Director Grant (A) $89K
Price $87.40 Qty 1K Owned 108K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Hubbard Robert Glenn Director Grant (A) $87.40 1K $89K 108K Jun 16, 2026 Jun 18, 2026
Harris Carla A. · Director Grant (A) $51K
Price $87.40 Qty 587 Owned 11K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Harris Carla A. Director Grant (A) $87.40 587 $51K 11K Jun 16, 2026 Jun 18, 2026
Seitz Michelle · Director Grant (A) 587
Owned 2K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Seitz Michelle Director Grant (A) 587 2K Jun 16, 2026 Jun 18, 2026
Glaser Daniel S. · Director Grant (A) $51K
Price $87.40 Qty 587 Owned 3K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Glaser Daniel S. Director Grant (A) $87.40 587 $51K 3K Jun 16, 2026 Jun 18, 2026
Weinberger Mark A. · Director Grant (A) 587
Owned 19K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Weinberger Mark A. Director Grant (A) 587 19K Jun 16, 2026 Jun 18, 2026
McKenzie Diana · Director Grant (A) $14K
Price $85.57 Qty 169 Owned 25K Trade date Jun 9, 2026 Filed date Jun 11, 2026
McKenzie Diana Director Grant (A) $85.57 169 $14K 25K Jun 9, 2026 Jun 11, 2026
Kennard William E. · Director Grant (A) $28K
Price $85.57 Qty 322 Owned 47K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Kennard William E. Director Grant (A) $85.57 322 $28K 47K Jun 9, 2026 Jun 11, 2026
Hay Laura J. · Director Grant (A) $3K
Price $85.57 Qty 39 Owned 6K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Hay Laura J. Director Grant (A) $85.57 39 $3K 6K Jun 9, 2026 Jun 11, 2026
Johnson Jeh C. · Director Grant (A) $5K
Price $85.57 Qty 61 Owned 9K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Johnson Jeh C. Director Grant (A) $85.57 61 $5K 9K Jun 9, 2026 Jun 11, 2026
Harris Carla A. · Director Grant (A) $4K
Price $85.57 Qty 42 Owned 11K Trade date Jun 9, 2026 Filed date Jun 11, 2026
Harris Carla A. Director Grant (A) $85.57 42 $4K 11K Jun 9, 2026 Jun 11, 2026
15 of 100
15 of 100 Sign in to continue to older insider transactions.

MetLife, Inc. (MET) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Board of Directors of Metlife Inc 112.3M
% of shares outstanding 16.2% Filing date Nov 1, 2024
Board of Directors of Metlife Inc 112.3M 16.2% Nov 1, 2024
Vanguard Group Inc 57.6M
% of shares outstanding 7.8% Filing date Feb 13, 2024
Vanguard Group Inc 57.6M 7.8% Feb 13, 2024
Dodge & Cox 53.4M
% of shares outstanding 7.2% Filing date Feb 13, 2024
Dodge & Cox 53.4M 7.2% Feb 13, 2024
BlackRock Inc. 52.7M
% of shares outstanding 7.1% Filing date Jan 26, 2024
BlackRock Inc. 52.7M 7.1% Jan 26, 2024
Vanguard Capital Management 41.5M
% of shares outstanding 6.4% Filing date Apr 30, 2026
Vanguard Capital Management 41.5M 6.4% Apr 30, 2026
5 of 5

MetLife, Inc. (MET) ownership FAQ

Who owns MET?

1,280 reporting institutions disclosed MET position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.